Advertisement

Renal Companies in BioPortfolio's Corporate DatabaseTwitter RSS

00:22 EDT 19th June 2013 | BioPortfolio

Renal company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Renal companies that have been added to our BioPortfolio's life-science corporate directory.

Search For More Renal Companies

If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Renal Companies.

More Information about Renal on BioPortfolio

We have published hundreds of Renal news stories on BioPortfolio along with dozens of Renal Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Renal for you to read.

Showing "renal urinary kidney" Companies 1 to 25 of 223

Monday 17th June 2013

ADC Therapeutics

ADC Therapeutics sarl (ADCT) is a Swiss-based oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers such as breast lung, prostate, renal and blood. The Company’s ADCs are highly targeted drug constructs which combine monoclonal antibodies specific to particular types of...

Thursday 13th June 2013

Life Line Screening

Life Line Screening is a preventive health company and a leading provider of community-based screenings in the United States, United Kingdom, and Australia. Since inception in 1993, Life Line Screening has screened over 8 million people, and currently screens about 1 million people each year at more than 15,000 screening events. In addition, Life Line Scre...

Monday 10th June 2013

Concert Pharmaceuticals Inc.

Concert Pharmaceuticals is a clinical stage biotechnology company with a broad development pipeline targeting renal disease, CNS disorders, inflammation and hematologic disorders. Concert is focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs and leveraging decades of pharma...

Monday 20th May 2013

Renal Ventures Management, LLC

Renal Ventures Management, LLC is a leading provider of dialysis services. The company partners with top physicians to provide patients with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its nephrologist partners, Renal Ventures Management provides management expertise and patient-focused care operations which ce...

Thursday 16th May 2013

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and gr...

Saturday 4th May 2013

Symbollon Pharmaceuticals

Symbollon is a specialty pharmaceutical company focused on the development and commercialization of proprietary drugs based on its I2 technology. I2 is the chemical symbol for molecular iodine. Molecular iodine is the active species of iodine, a proven fast acting, broad-spectrum antimicrobial and therapeutic. Formed in 1986, Symbollon completed its initial public offering in December 1993. Since...

Tissue Regeneration Technologies, LLC

TRT is an international medical device company established to develop, manufacture and sell SoftWaveTM acoustical pressure pulse devices to treat various conditions poorly served by the current standard of care. TRT is headquartered in Woodstock, Georgia. Production of TRT’s devices is handled by its manufacturing subsidiary, MTS Europe GmbH, located...

Relypsa Inc.

Relypsa, Inc. is a, clinical-stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases. Relypsa's lead product candidate is RLY5016, a non-absorbed potassium binder for the treatment of hyperkalemia. Relypsa is dedicated to the discovery of add...

Kite Pharma, Inc.

Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the design and development of cutting-edge immunotherapeutic products to treat different cancer indications. Kite's lead products include antigens associated with a wide variety of tumor types, and are initially being developed for the treatment of renal cell carcinoma...

Shad Ireland Foundation

Global Mission Statement: Committed to education, prevention, awareness, and access, the Shad Ireland Foundation is an international non-profit organization that is actively exploring ways to further develop and expand its global impact on kidney diseases and their leading causes. In countries around the world the organization creates strategic relationshi...

American Renal Holdings

American Renal Associates LLC (“ARA”) is the operating subsidiary of American Renal Holdings, Inc. and is a leading owner and provider of outpatient kidney dialysis centers operating centers in partnership with nephrologists throughout the United States. The Company’s unique operating philosophy merges physician autonomy, leading edge patient...

Baxter International Inc. and Takeda Pharmaceutical Company Limited

Baxter International Inc. (NYSE: BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combina...

Clear Catheter Systems, Inc.

Clear Catheter Systems is a Bend, Oregon based medical device company developing an anti-clogging platform of surgical drainage devices. Its lead product is the PleuraFlow Catheter, which addresses the problem of chest tube clogging after heart and lung surgery. In addition, Clear Catheter has a pipeline of products based on its proprietary tube clearance...

Santarus, Inc. and Pharming Group NV

Pharming Group NV is developing innovative products for the treatment of unmet medical needs. RUCONEST™ (RHUCIN® in non-European territories) is a recombinant human C1 inhibitor approved for the treatment of angioedema attacks in patients with HAE in all 27 EU countries plus Norway, Iceland and Liechtenstein. The product is also under development f...

Achaogen, Inc.

Achaogen is a clinical-stage biopharmaceutical company focused on the discovery and development of antibiotics for the treatment of serious infections caused by multi-drug resistant, Gram-negative bacteria. The company’s pipeline includes ACHN-490, an aminoglycoside currently being evaluated in a Phase 2 clinical study for the treatment of complicated...

Falcon, LLC.

Falcon EHRTM helps physicians manage kidney patients’ health records from CKD through ESRD and can be accessed wherever there is Internet access. Developed, tested and endorsed by kidney professionals in the doctor’s office, Falcon EHR is powered by DaVita® and supported by a dedicated, award-winning 24/7 Falcon support team. For more informat...

Orchid Medical

Founded in 2002, Orlando-based Orchid Medical is a nationwide ancillary healthcare service company specializing in workers' compensation. Its high level of efficiency and standards of quality care solutions expedite successful outcomes for injured workers. Its ancillary medical services include DME, Orthotics & Prosthetics, Home Health Care,...

Thrasos Innovation, Inc.

Thrasos is a private, clinical stage, bio-therapeutics Company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ failure, with a principle focus on kidney disease. The Company’s first drug candidates were selected from an extensive inventory of active peptide compounds generated by the Comp...

Thrasos, Inc.

Thrasos is a private, clinical stage, bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The Company has advanced two compounds, THR-184 and THR-123, into development for Acute Kidney Injury (AKI) and Chronic Kidney Injury (CKD), respectively, and initiated Phase 1 cli...

Vivere Health, LLC

Vivere Health is a leading network of Fertility Centers of Excellence. The company, recently founded in 2010, serves as the business backbone for leading reproductive endocrinologists nationally, developing Ambulatory Surgery Centers and IVF laboratories. Vivere’s primary focus is to improve quality outcomes by enabling the strategic expansion of g...

Oceana Therapeutics LLC

Oceana Therapeutics is committed to commercializing best-in-class therapeutics to address unmet and under-satisfied medical needs with a focus on colorectal, gastroenterology and urological diseases. With executive offices in Edison, NJ and European operations headquartered in Dublin, Ireland, Oceana is exceptionally well positioned to pursue worldwide...

DaVita Labs

DaVita Labs, a division operating within DaVita Inc., provides quality, on-time, accurate results to help effectively identify and manage kidney patients across the nation. As a cutting-edge chronic kidney disease (CKD) specialty laboratory, DaVita Labs features the latest in end stage renal disease-specific methodology and technology for delivering quality...

Spectra Laboratories, Inc.

Established in 1982, Spectra Laboratories, Inc. is the leading provider of renal-specific laboratory testing services in the United States. The company’s state-of-the-art analytical equipment, automated specimen processing, and reporting applications provide more than 54 million rapid and reliable test results annually, reaching over 162,000 renal pat...

DaVita, Inc.

DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and con...

AlloCure, Inc.

AlloCure, Inc. is a privately held company focused on the treatment of kidney disease. The company is a leader in the AKI field and is pioneering the development of the first effective therapy for the treatment of AKI. The company’s headquarters is located in Burlington, MA. For more information about AlloCure, please visit the company’s web site...


More From BioPortfolio on "Renal Companies in BioPortfolio's Corporate Database"

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks

Advertisement